Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis

Inclusion Criteria

• •Premenopausal women aged 18-48 inclusive
• •Endometriosis documented by laparoscopic or surgical assessment within the past ten (10) years
• •Clinical symptoms of endometriosis for at least the past three (3) months
• •Endometriosis symptoms
• •Must be sexually active unless sexually inactive for endometriosis-related dyspareunia
• •Must have a regular or steady menstrual cycle lasting from 24 to 36 days and a detectable ovulation during the baseline period using an ovulation monitoring kit (for timing of endometrial biopsy)